Skip to content

Study · Case report or series · n = 1 · 2025

2 results

A Case of Intussusception With Bowel Obstruction in a Gastric Roux-en-Y Patient Prescribed Semaglutide.

Pavuluri SK, Toumar A, Duffy AJ

Journal of the American College of Emergency Physicians open30 Jan 2025Cited by 3 (Europe PMC)

PMID39959551 (opens in a new tab)PMCIDPMC11830288 (opens in a new tab)DOI10.1016/j.acepjo.2025.100045 (opens in a new tab)PepBankPUB-39959551
Read at sourcePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanCase report or seriesSafety outcome

    In one woman with prior Roux-en-Y gastric bypass, intussusception with small bowel obstruction developed after semaglutide was prescribed.

    In plain wordsOne woman with earlier gastric bypass surgery developed a bowel blockage after being prescribed semaglutide.

    Peptide
    Semaglutide
    Outcome
    Not applicableIntussusception with small bowel obstruction
    Study

    n = 1

    Outcome group
    Adverse events · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    subsequently developed intussusception with small bowel obstruction and chemical pancreatitis.
    2 context sentences
    Summary · context
    Laparoscopic surgical intervention was required, ultimately converted to a laparotomy for successful reduction of the intussusception.
    Summary · context
    This case report presents a 59-year-old woman with a previous Roux-en-Y gastric bypass who was prescribed semaglutide, and subsequently developed intussusception with small bowel obstruction and chemical pancreatitis.
  2. 02HumanCase report or seriesSafety outcome

    In one woman with prior Roux-en-Y gastric bypass, chemical pancreatitis developed after semaglutide was prescribed.

    In plain wordsOne woman with earlier gastric bypass surgery developed pancreatitis after being prescribed semaglutide.

    Peptide
    Semaglutide
    Outcome
    Not applicableChemical pancreatitis
    Study

    n = 1

    Outcome group
    Adverse events · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    and chemical pancreatitis.
    1 context sentence
    Summary · context
    This case report presents a 59-year-old woman with a previous Roux-en-Y gastric bypass who was prescribed semaglutide, and subsequently developed intussusception with small bowel obstruction and chemical pancreatitis.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:04 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:06 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.